3-(1,3,2-Dioxaborinan-2-yl)pyridine → HCID 18007513, compound

HRID 988102Notes

Reaction equation

HRID 988102 reaction equation
Br[C:2]1[CH:10]=[C:9]2[C:5]([CH:6]=[C:7](C(C3CCCN3)C)[NH:8]2)=[CH:4][CH:3]=1.B1([C:24]2[CH:29]=[CH:28][CH:27]=[N:26][CH:25]=2)OCCCO1>>[NH:8]1[CH2:7][CH2:6][CH2:5][CH:9]1[CH:10]([N:8]1[C:9]2[C:5](=[CH:4][CH:3]=[C:2]([C:28]3[CH:27]=[N:26][CH:25]=[CH:24][CH:29]=3)[CH:10]=2)[CH:6]=[CH:7]1)[CH3:2]

Participants

3

Reactant 2

HCID 41980053-(1,3,2-Dioxaborinan-2-yl)pyridineHCID 70035657HCID 70035657, compound

Product 1

HCID 18007513HCID 18007513, compound

Procedure

(9.3 mg, 49%); from 6-Bromo-1-(2-pyrrolidinyl)ethyl indole (19.0 mg, 0.065 mmol) and pyridine-3-boronic acid 1,3-propanediol cyclic ester (21.0 mg, 0.130 mmol).

Sources & evidence

ORD record
ord-33276203cceb4d4b8c166bc9aaad1b7b
Source dataset
uspto-grants-2003_10
Patent number
US06635639B2

Reaction notes

Loading…